Telix Pharmaceuticals Limited (ASX:TLX)
Australia
· Delayed Price · Currency is AUD 10.00
-0.20 (-1.96%)
At close: Feb 27, 2026
Telix Pharmaceuticals Market Cap
Telix Pharmaceuticals has a market cap or net worth of 3.39 billion as of February 27, 2026. Its market cap has decreased by -63.26% in one year.
Market Cap
3.39B
Enterprise Value
3.88B
Revenue
1.21B
Ranking
n/a
PE Ratio
n/a
Stock Price
10.00
Market Cap Chart
Since November 15, 2017, Telix Pharmaceuticals's market cap has increased from 152.03M to 3.39B, an increase of 2,128.40%. That is a compound annual growth rate of 45.41%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mesoblast | 2.89B |
| Neuren Pharmaceuticals | 1.65B |
| PYC Therapeutics | 1.42B |
| Clarity Pharmaceuticals | 1.34B |
| Opthea | 738.77M |
| Immutep | 567.38M |
| Clinuvel Pharmaceuticals | 502.51M |
| Racura Oncology | 448.80M |